AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/250
LACK OF SEROLOGIC ASSOCIATION BETWEEN HUMAN-HERPESVIRUS-8 INFECTION AND MULTIPLE-MYELOMA AND MONOCLONAL GAMMOPATHIES OF UNDETERMINED SIGNIFICANCE
Authors: SANTARELLI R ANGELONI A FARINA A GONNELLA R GENTILE G MARTINO P PETRUCCI MT MANDELLI F FRATI L FAGGIONI A
Citation: R. Santarelli et al., LACK OF SEROLOGIC ASSOCIATION BETWEEN HUMAN-HERPESVIRUS-8 INFECTION AND MULTIPLE-MYELOMA AND MONOCLONAL GAMMOPATHIES OF UNDETERMINED SIGNIFICANCE, Journal of the National Cancer Institute, 90(10), 1998, pp. 781-782
DRUG-USE AND ACUTE-LEUKEMIA
Authors: TRAVERSA G MENNITIIPPOLITO F DACAS R MELE A PULSONI A MANDELLI F
Citation: G. Traversa et al., DRUG-USE AND ACUTE-LEUKEMIA, Pharmacoepidemiology and drug safety, 7(2), 1998, pp. 113-123
THE RISK OF ACUTE-LEUKEMIA IN PATIENTS TREATED FOR HODGKINS-DISEASE IS SIGNIFICANTLY HIGHER AFTER COMBINED-MODALITY PROGRAMS THAN AFTER CHEMOTHERAPY ALONE AND IS CORRELATED WITH THE EXTENT OF RADIOTHERAPY AND TYPE AND DURATION OF CHEMOTHERAPY - A CASE-CONTROL STUDY
Authors: BRUSAMOLINO E ANSELMO AP KLERSY C SANTORO M ORLANDI E PAGNUCCO G LUNGHI F MAURIZIENRICI R BARONI CD LAZZARINO M MANDELLI F BERNASCONI C
Citation: E. Brusamolino et al., THE RISK OF ACUTE-LEUKEMIA IN PATIENTS TREATED FOR HODGKINS-DISEASE IS SIGNIFICANTLY HIGHER AFTER COMBINED-MODALITY PROGRAMS THAN AFTER CHEMOTHERAPY ALONE AND IS CORRELATED WITH THE EXTENT OF RADIOTHERAPY AND TYPE AND DURATION OF CHEMOTHERAPY - A CASE-CONTROL STUDY, Haematologica, 83(9), 1998, pp. 812-823
THE RISK OF NON-HODGKINS-LYMPHOMA AFTER HODGKINS-DISEASE, WITH SPECIAL REFERENCE TO SPLENIC TREATMENT
Authors: ENRICI RM ANSELMO AP IACARI V OSTI MF SANTORO M TOMBOLINI V MANDELLI F BIAGINI C
Citation: Rm. Enrici et al., THE RISK OF NON-HODGKINS-LYMPHOMA AFTER HODGKINS-DISEASE, WITH SPECIAL REFERENCE TO SPLENIC TREATMENT, Haematologica, 83(7), 1998, pp. 636-644
COMBINED-MODALITY THERAPY IN ADVANCED HODGKINS-DISEASE - A REPORT ON 218 PATIENTS WITH A MEDIAN FOLLOW-UP OF 8 YEARS
Authors: ANSELMO AP CAVALIERI E ENRICI RM DONATO V PESCARMONA E BIAGINI C MANDELLI F
Citation: Ap. Anselmo et al., COMBINED-MODALITY THERAPY IN ADVANCED HODGKINS-DISEASE - A REPORT ON 218 PATIENTS WITH A MEDIAN FOLLOW-UP OF 8 YEARS, Haematologica, 83(7), 1998, pp. 645-650
CHRONIC LYMPHOCYTIC-LEUKEMIA - FROM PALLIATIVE THERAPY TO CURATIVE INTENT
Authors: MELONI G MAURO FR PROIA A MANDELLI F
Citation: G. Meloni et al., CHRONIC LYMPHOCYTIC-LEUKEMIA - FROM PALLIATIVE THERAPY TO CURATIVE INTENT, Haematologica, 83(7), 1998, pp. 660-662
RANDOMIZED PHASE-III STUDY OF INTERLEUKIN-3 (RHIL-3) AS ADJUVANT TO IEV-CHEMOTHERAPY FOR RELAPSING AGGRESSIVE LYMPHOMAS
Authors: GERHARTZ HH MANDELLI F PHILIP T TURA S HEINZ R GREIL R SENN HJ HUBER C BLAU W FARBER L SKLENAR I HAUS U
Citation: Hh. Gerhartz et al., RANDOMIZED PHASE-III STUDY OF INTERLEUKIN-3 (RHIL-3) AS ADJUVANT TO IEV-CHEMOTHERAPY FOR RELAPSING AGGRESSIVE LYMPHOMAS, Bone marrow transplantation, 22, 1998, pp. 11-11
UMBILICAL-CORD BLOOD TRANSPLANT FROM HLA-MISMATCHED UNRELATED DONOR IN HIGH-RISK LEUKEMIA
Authors: ARCESE W IORI AP SCRENCI M GUGLIELMI C MENGARELLI A CARMINI D TESTI AM MOLETI ML CIMINO G PERRONE P LAURENTI L ELIA L BOECKLIN F ROMANO A DEFELICE L MANDELLI F
Citation: W. Arcese et al., UMBILICAL-CORD BLOOD TRANSPLANT FROM HLA-MISMATCHED UNRELATED DONOR IN HIGH-RISK LEUKEMIA, Bone marrow transplantation, 21, 1998, pp. 85-86
RESULTS OF POSTCONSOLIDATION TREATMENT FOR PATIENTS LESS-THAN 51 YEARS OF AGE WITH AML IN FIRST CR IN THE AML 10 STUDY OF THE LEUKEMIA COOPERATIVE GROUP OF THE EORTC AND GIMEMA
Authors: KEATING S SUCIU S MANDELLI F DEWITTE T ZITTOUN R ARCHIMBAUD E RESEGOTTI L MELONI G FAZI P DARDENNE M WILLEMZE R
Citation: S. Keating et al., RESULTS OF POSTCONSOLIDATION TREATMENT FOR PATIENTS LESS-THAN 51 YEARS OF AGE WITH AML IN FIRST CR IN THE AML 10 STUDY OF THE LEUKEMIA COOPERATIVE GROUP OF THE EORTC AND GIMEMA, Bone marrow transplantation, 21, 1998, pp. 44-44
PBSC TRANSPLANTATION IN CLL PATIENTS IN REMISSION AFTER FLUDARABINE THERAPY
Authors: MELONI G MAURO F PROIA A CAPRIA S CORDONE I DEFABRITIIS P FOA R PESCARMONA E SPIRITO F MANDELLI F
Citation: G. Meloni et al., PBSC TRANSPLANTATION IN CLL PATIENTS IN REMISSION AFTER FLUDARABINE THERAPY, Bone marrow transplantation, 21, 1998, pp. 278-278
ABMT FOR CML IN BLASTIC CRISIS AND LONG-LASTING SLE - 3 YEARS REMISSION OF BOTH DISEASES
Authors: MELONI G CAPRIA S PROIA A TRASARTI S TRISOLINI SM MANDELLI F
Citation: G. Meloni et al., ABMT FOR CML IN BLASTIC CRISIS AND LONG-LASTING SLE - 3 YEARS REMISSION OF BOTH DISEASES, Bone marrow transplantation, 21, 1998, pp. 304-304
HIGH-DOSE IDARUBICINE, BUSULFAN AND MELPHALAN CONDITIONING REGIMEN FOR LYMPHOPROLIFERATIVE DISORDERS
Authors: TRASARTI S MELONI G CAPRIA S BONGARZONI V FERRAZZA G IODICE F PROIA A TRISOLINI SM MANDELLI F
Citation: S. Trasarti et al., HIGH-DOSE IDARUBICINE, BUSULFAN AND MELPHALAN CONDITIONING REGIMEN FOR LYMPHOPROLIFERATIVE DISORDERS, Bone marrow transplantation, 21, 1998, pp. 352-352
A SYSTEMATIC COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS COMPARING IDARUBICIN WITH DAUNORUBICIN (OR OTHER ANTHRACYCLINES) AS INDUCTION THERAPY FOR ACUTE MYELOID-LEUKEMIA
Authors: WHEATLEY D DUTCHER JP WIERNIK PH HUGUET F POLIN V REIFFERS J SOTTO JJ STOPPA AM MANDELLI F PETTI MC HAROUSSEAU JL MERCIER M POLIN V TELLIER Z BERMAN E STAGG M VOGLER WR BEZWODA WR ALISON R CLARKE M EVANS V GRAY R GREAVES E HALL E HICKS C JAMES S PETO R RICHARDS S SINCLAIR D TOOTH A WHEATLEY K
Citation: D. Wheatley et al., A SYSTEMATIC COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS COMPARING IDARUBICIN WITH DAUNORUBICIN (OR OTHER ANTHRACYCLINES) AS INDUCTION THERAPY FOR ACUTE MYELOID-LEUKEMIA, British Journal of Haematology, 103(1), 1998, pp. 100-109
THE INFLUENCE OF HLA-MATCHED SIBLING DONOR AVAILABILITY ON TREATMENT OUTCOME FOR PATIENTS WITH AML - AN ANALYSIS OF THE AML 8A STUDY OF THEEORTC-LEUKEMIA-COOPERATIVE-GROUP AND GIMEMA
Authors: KEATING S DEWITTE T SUCIU S WILLEMZE R HAYAT M LABAR B RESEGOTTI L FERRINI PR CARONIA F DARDENNE M SOLBU G PETTI MC VEGNA ML MANDELLI F ZITTOUN RA
Citation: S. Keating et al., THE INFLUENCE OF HLA-MATCHED SIBLING DONOR AVAILABILITY ON TREATMENT OUTCOME FOR PATIENTS WITH AML - AN ANALYSIS OF THE AML 8A STUDY OF THEEORTC-LEUKEMIA-COOPERATIVE-GROUP AND GIMEMA, British Journal of Haematology, 102(5), 1998, pp. 1344-1353
FISH INVESTIGATIONS ON 12P CHANGES WITH BREAKPOINT OUTSIDE ETV6 GENE IN ADULT AML-MDS
Authors: LASTARZA E MECUCCI C MARYNEN P TESTONI N DIBONA E STELLA M CIOLLI S MARTELLI MF MANDELLI F
Citation: E. Lastarza et al., FISH INVESTIGATIONS ON 12P CHANGES WITH BREAKPOINT OUTSIDE ETV6 GENE IN ADULT AML-MDS, British Journal of Haematology, 102(1), 1998, pp. 33-33
21 CASES OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA FOLLOWING A PREVIOUS NEOPLASTIC MALIGNANCY
Authors: PULSONI A PAGANO L INVERNIZZI R DIBONA E BASSAN R CASTAGNOLA C MARTINO B MELE A TOSTI M ANNINO L CERRI R CAMERA A MANNA A CORVATTA L TODESCHINI G DELPOETA G ALMICI C LANZA F SANTUARI L RECCHIA A MELE L LEONE G MANDELLI F
Citation: A. Pulsoni et al., 21 CASES OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA FOLLOWING A PREVIOUS NEOPLASTIC MALIGNANCY, British Journal of Haematology, 102(1), 1998, pp. 36-36
ACUTE PROMYELOCYTIC LEUKEMIA (APL) - EPIDEMIOLOGY AND RISK-FACTORS - DATA FROM THE GIMEMA ARCHIVE OF ADULT ACUTE-LEUKEMIA
Authors: PULSONI A STAZI MA ALLIONE B CAMERA A COTICHINI R DEPLANO W FIORITONI G NOSARI AM PAGANO L RIBERSANI M ROCCHI L SIMONE MD TODESCHINI G VISANI G MELE A MANDELLI F
Citation: A. Pulsoni et al., ACUTE PROMYELOCYTIC LEUKEMIA (APL) - EPIDEMIOLOGY AND RISK-FACTORS - DATA FROM THE GIMEMA ARCHIVE OF ADULT ACUTE-LEUKEMIA, British Journal of Haematology, 102(1), 1998, pp. 36-36
SECONDARY ACUTE-LEUKEMIA - REPORT OF GIMEMA ARCHIVE OF ADULT ACUTE-LEUKEMIA
Authors: PAGANO L PULSONI A INVERNIZZI R DIBONA E CLAVIO M VISANI G MARTINO B MELE A TOSTI N CERRI R CAMERA A CORVATTA L LEVIS A COSER P NOSARI A ALLIONE B MICELI S ALMICI C CANDONI A MASINI L VISCHIA F RECCHIA A EQUITANI F LEONE G MANDELLI F
Citation: L. Pagano et al., SECONDARY ACUTE-LEUKEMIA - REPORT OF GIMEMA ARCHIVE OF ADULT ACUTE-LEUKEMIA, British Journal of Haematology, 102(1), 1998, pp. 37-37
THERAPY OF MINIMAL DISEASE RECURRENCE IN ACUTE PROMYELOCYTIC LEUKEMIA
Authors: LOCOCO F DIVERIO D PETTI MC AVVISATI G POGLIANI EM BIONDI A MELONI G MANDELLI F
Citation: F. Lococo et al., THERAPY OF MINIMAL DISEASE RECURRENCE IN ACUTE PROMYELOCYTIC LEUKEMIA, British Journal of Haematology, 102(1), 1998, pp. 149-149
HIGH-DOSE HYDROXYUREA (HIGH-HY) IN THE TREATMENT OF POOR-RISK ACUTE MYELOID-LEUKEMIA
Authors: PETTI MC SPIRITI MAA MONTEFUSCO E REDI R MANCINI M COMANDINI A DELIA GM MANDELLI F
Citation: Mc. Petti et al., HIGH-DOSE HYDROXYUREA (HIGH-HY) IN THE TREATMENT OF POOR-RISK ACUTE MYELOID-LEUKEMIA, British Journal of Haematology, 102(1), 1998, pp. 222-222
EARLY DISCHARGE AND HOME CARE MANAGEMENT OF THERAPY-INDUCED NEUTROPENIC AML PATIENTS
Authors: CARTONI C CEDRONE M DEGREGORIIS C DESANCTIS V GIOVANNINI M NISCOLA P ROMANI C MOLETI ML ANDRIZZI C TOSTI S GIRMENIA C MANDELLI F
Citation: C. Cartoni et al., EARLY DISCHARGE AND HOME CARE MANAGEMENT OF THERAPY-INDUCED NEUTROPENIC AML PATIENTS, British Journal of Haematology, 102(1), 1998, pp. 224-224
CLINICAL RELEVANCE OF BCR ABL AND ALL1/AF4 MOLECULAR MARKERS IN ADULTACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - A RETROSPECTIVE STUDY/
Authors: ANNINO L ELIA L LAMANDA M FERRARI A VEGNA ML RAPANOTTI MC BUFFOLINO S LOCOCO F CIMINO G MANDELLI F
Citation: L. Annino et al., CLINICAL RELEVANCE OF BCR ABL AND ALL1/AF4 MOLECULAR MARKERS IN ADULTACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - A RETROSPECTIVE STUDY/, British Journal of Haematology, 102(1), 1998, pp. 227-227
SINGLE HIGH-DOSE OF IDARUBICIN AND HIGH-DOSE ARA-C COMBINATION (MSKCCALL3 PROTOCOL) IN ADULT AND PEDIATRIC-PATIENTS WITH ADVANCED ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) AND NON-HODGKIN-LYMPHOMA (NHL) - A GIMEMA-AIEOP MULTICENTRIC STUDY
Authors: ANNINO L TESTI AM LAMANDA M DELGIUDICE I MOLETI ML BARISONE E MICALIZZI C RIZZARI C TABILIO A MANDELLI F WEISS M
Citation: L. Annino et al., SINGLE HIGH-DOSE OF IDARUBICIN AND HIGH-DOSE ARA-C COMBINATION (MSKCCALL3 PROTOCOL) IN ADULT AND PEDIATRIC-PATIENTS WITH ADVANCED ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) AND NON-HODGKIN-LYMPHOMA (NHL) - A GIMEMA-AIEOP MULTICENTRIC STUDY, British Journal of Haematology, 102(1), 1998, pp. 228-228
MACOP-B PLUS INVOLVED FIELD RADIATION-THERAPY IS AN EFFECTIVE THERAPYFOR PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (MLBCL)
Authors: MARTELLI MP MARTELLI M PESCARMONA E DESANCTIS V DONATO V PALOMBI F LUZI G SCARAMUCCI L MANDELLI F
Citation: Mp. Martelli et al., MACOP-B PLUS INVOLVED FIELD RADIATION-THERAPY IS AN EFFECTIVE THERAPYFOR PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (MLBCL), British Journal of Haematology, 102(1), 1998, pp. 239-239
HEART-DISEASE IN AIDS-RELATED LYMPHOMA PATIENTS (L-AIDS PTS) - IMPACTOF ANTINEOPLASTIC CHEMOTHERAPY (CT)
Authors: TORROMEO C GASTALDI R ROMANI C MANDELLI F
Citation: C. Torromeo et al., HEART-DISEASE IN AIDS-RELATED LYMPHOMA PATIENTS (L-AIDS PTS) - IMPACTOF ANTINEOPLASTIC CHEMOTHERAPY (CT), British Journal of Haematology, 102(1), 1998, pp. 240-240
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>